Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  227 results for ""Scleroderma, Systemic""

Your Filters

Geographic : japan
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Advancements in the treatment of interstitial lung disease in systemic sclerosis with the approval of mycophenolate mofetil.

  • Authors : Takada T; Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, 4132, Urasa, Minami-uonuma, Niigata, 949-7302, Japan. Electronic address: .; Aoki A

Subjects: Lung Diseases, Interstitial*/Lung Diseases, Interstitial*/Lung Diseases, Interstitial*/etiology ; Lung Diseases, Interstitial*/Lung Diseases, Interstitial*/Lung Diseases, Interstitial*/drug therapy ; Mycophenolic Acid*/Mycophenolic Acid*/Mycophenolic Acid*/therapeutic use

  • Source: Respiratory investigation [Respir Investig] 2024 Nov; Vol. 62 (6), pp. 1242-1246. Date of Electronic Publication: 2024 Nov 14.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101581124 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Reliability, validity, and sensitivity of the Japanese version of the University of California Los Angeles scleroderma clinical trial consortium gastrointestinal tract instrument: Application to efficacy assessment of intravenous immunoglobulin administration.

  • Authors : Matsuda KM; Department of Dermatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.; Sugimoto E

Subjects: Immunoglobulins, Intravenous*/Immunoglobulins, Intravenous*/Immunoglobulins, Intravenous*/administration & dosage ; Immunoglobulins, Intravenous*/Immunoglobulins, Intravenous*/Immunoglobulins, Intravenous*/therapeutic use ; Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/drug therapy

  • Source: The Journal of dermatology [J Dermatol] 2024 Jun; Vol. 51 (6), pp. 741-751. Date of Electronic Publication: 2024 Apr 01.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7600545 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Editorial & Opinion

ELISA detection of anti-eIF2B antibodies in Japanese patients with systemic sclerosis.

  • Authors : Koizumi H; Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.; Yamano Y

Subjects: Autoantibodies*/Autoantibodies*/Autoantibodies*/blood ; Enzyme-Linked Immunosorbent Assay* ; Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/immunology

  • Source: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 May 03; Vol. 63 (6), pp. e164-e165.Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Early initiation of angiotensin-converting enzyme inhibitor in patients with scleroderma renal crisis: a nationwide inpatient database study.

  • Authors : Ida T; Department of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan.; Ikeda K

Subjects: Angiotensin-Converting Enzyme Inhibitors*/Angiotensin-Converting Enzyme Inhibitors*/Angiotensin-Converting Enzyme Inhibitors*/therapeutic use ; Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/complications ; Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/drug therapy

  • Source: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 May 03; Vol. 63 (6), pp. 1507-1511.Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Prevalence and risk factors for medication-refractory reflux esophagitis in patients with systemic sclerosis in Japan.

  • Authors : Kuribayashi S; Department of Gastroenterology and Hepatology, Gunma University Graduate School of Medicine, 3-39-15 Showa-Machi Maebashi, Gunma, 371-8511, Japan. .; Nakamura F

Subjects: Esophagitis, Peptic*/Esophagitis, Peptic*/Esophagitis, Peptic*/drug therapy ; Esophagitis, Peptic*/Esophagitis, Peptic*/Esophagitis, Peptic*/epidemiology ; Esophagitis, Peptic*/Esophagitis, Peptic*/Esophagitis, Peptic*/etiology

  • Source: Journal of gastroenterology [J Gastroenterol] 2024 Mar; Vol. 59 (3), pp. 179-186. Date of Electronic Publication: 2024 Jan 22.Publisher: Springer International Country of Publication: Japan NLM ID: 9430794 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Absence of interstitial lung disease at initial visit may predict a favorable outcome for Japanese patients with systemic sclerosis with anti-topoisomerase I antibody.

  • Authors : Hamaguchi Y; Department of Dermatology, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.; Yoshimura Y

Subjects: Lung Diseases, Interstitial*/Lung Diseases, Interstitial*/Lung Diseases, Interstitial*/diagnosis ; Lung Diseases, Interstitial*/Lung Diseases, Interstitial*/Lung Diseases, Interstitial*/drug therapy ; Lung Diseases, Interstitial*/Lung Diseases, Interstitial*/Lung Diseases, Interstitial*/etiology

  • Source: The Journal of dermatology [J Dermatol] 2024 Jan; Vol. 51 (1), pp. 62-69. Date of Electronic Publication: 2023 Oct 21.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7600545 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy and safety of tocilizumab in Japanese patients with systemic sclerosis and associated interstitial lung disease: A subgroup analysis of a global, randomised, controlled Phase 3 trial.

  • Authors : Kuwana M; Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan.; Takehara K

Subjects: Lung Diseases, Interstitial*/Lung Diseases, Interstitial*/Lung Diseases, Interstitial*/complications ; Lung Diseases, Interstitial*/Lung Diseases, Interstitial*/Lung Diseases, Interstitial*/drug therapy ; Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/complications

  • Source: Modern rheumatology [Mod Rheumatol] 2024 Mar 28; Vol. 34 (3), pp. 530-540.Publisher: Oxford University Press Country of Publication: England NLM ID: 100959226 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Persistent Risk of Developing Autoimmune Diseases Associated With COVID-19: An Observational Study Using an Electronic Medical Record Database in Japan.

  • Authors : Inokuchi S; From the Research and Analytics Department, Real World Data Co, Ltd, Kyoto, Japan.; Shimamoto K

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; Immunoglobulin G4-Related Disease* ; Autoimmune Diseases*/Autoimmune Diseases*/Autoimmune Diseases*/epidemiology

  • Source: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases [J Clin Rheumatol] 2024 Mar 01; Vol. 30 (2), pp. 65-72. Date of Electronic Publication: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9518034 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Latent trajectory modelling of pulmonary artery pressure in systemic sclerosis: a retrospective cohort study.

  • Authors : Kida T; Department of Preventive Services, School of Public Health, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Subjects: Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/complications ; Hypertension, Pulmonary*/Hypertension, Pulmonary*/Hypertension, Pulmonary*/etiology ; Hypertension, Pulmonary*/Hypertension, Pulmonary*/Hypertension, Pulmonary*/complications

  • Source: RMD open [RMD Open] 2022 Dec; Vol. 8 (2).Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Print Cited Medium: Internet ISSN: 2056-5933

Record details

Read More Add to Saved list
×
Academic Journal

Clinical worsening following discontinuation of tocilizumab in diffuse cutaneous systemic sclerosis: a single-centre experience in Japan.

  • Authors : Isomura Y; Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine.; Shirai Y

Subjects: Scleroderma, Diffuse*/Scleroderma, Diffuse*/Scleroderma, Diffuse*/drug therapy ; Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/drug therapy; Humans

  • Source: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2022 Nov 02; Vol. 61 (11), pp. 4491-4496.Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  227 results for ""Scleroderma, Systemic""